Pfizer’s Lipitor had sales of $2.39 billion in the first quarter falling short of the $2.55 billion average estimate of five analysts surveyed by Bloomberg. Photographer: JB Reed/Bloomberg
Pfizer’s Lipitor had sales of $2.39 billion in the first quarter falling short of the $2.55 billion average estimate of five analysts surveyed by Bloomberg. Photographer: JB Reed/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=534246724&utmp=%2Fphoto%2F2011-05-03%2Fpfizer-profit-beats-analysts-estimates-on-cost-reductions-prevnar-sales&utmhn=10.248.179.14&utmac=UA-11413116-12&utmhid=768248294)